Catalogo Articoli (Spogli Riviste)

HELP
ATTENZIONE: attualmente gli articoli Current Contents (fonte ISI) a partire dall'anno 2002 sono consultabili sulla Risorsa On-Line

Le informazioni sugli articoli di fonte ISI sono coperte da copyright

La ricerca find articoli where authors phrase all words ' Marolleau, JP' sort by level,fasc_key/DESCEND, pagina_ini_num/ASCEND ha restituito 74 riferimenti
Selezionare un intervallo

Per ulteriori informazioni selezionare i riferimenti di interesse.

    1. Michelson, S; Rohrlich, P; Beisser, P; Laurent, L; Perret, E; Prevost, MC; Monchatre, E; Duval, M; Marolleau, JP; Charbord, P
      Human cytomegalovirus infection of bone marrow myofibroblasts enhances myeloid progenitor adhesion and elicits viral transmission

      MICROBES AND INFECTION
    2. Terme, M; Masurier, C; Fernandez, N; Lacassagne, MN; Marolleau, JP; Zitvogel, L
      Role of dendritic cells in the modulation of innate immunity effecters.

      PATHOLOGIE BIOLOGIE
    3. Rocha, V; Carmagnat, MV; Chevret, S; Flinois, O; Bittencourt, H; Esperou, H; Garnier, F; Ribaud, P; Devergie, A; Socie, G; Dal'Cortivo, L; Marolleau, JP; Charron, D; Gluckman, E; Rabian, C
      Influence of bone marrow graft lymphocyte subsets on outcome after HLA-identical sibling transplants

      EXPERIMENTAL HEMATOLOGY
    4. Morariu-Zamfir, R; Rocha, V; Devergie, A; Socie, G; Ribaud, P; Esperou, H; Parquet, N; Guardiola, P; Dal Cortivo, L; Bittencourt, H; Garnier, F; Traineau, R; Marolleau, JP; Chevret, S; Gluckman, E
      Influence of CD34(+) marrow cell dose on outcome of HLA-identical sibling allogeneic bone marrow transplants in patients with chronic myeloid leukaemia

      BONE MARROW TRANSPLANTATION
    5. Costello, R; Sainty, D; Bouabdallah, R; Fermand, JP; Delmer, A; Divine, M; Marolleau, JP; Gastaut, JA; Olive, D; Rousselot, P; Chaibi, P
      Primary plasma cell leukaemia: a report of 18 cases

      LEUKEMIA RESEARCH
    6. Menasche, P; Hagege, AA; Scorsin, M; Pouzet, B; Desnos, M; Duboc, D; Schwartz, K; Vilquin, JT; Marolleau, JP
      Myoblast transplantation for heart failure

      LANCET
    7. Dosquet, C; Chen, Y; Makke, J; Miclea, JM; Coudert, MC; Marolleau, JP; Fermand, JP; Cottu, P; Lotz, JP; Benbunan, M
      Cytokines and vascular cell adhesion molecule-1 in the blood of patients undergoing HPC mobilization

      TRANSFUSION
    8. Menasche, P; Hagege, A; Scorsin, M; Pouzet, B; Desnos, M; Duboc, D; Schwartz, K; Vilquin, JT; Marolleau, JP
      Autologous skeletal myoblast transplantation for cardiac failure. First clinical case report.

      ARCHIVES DES MALADIES DU COEUR ET DES VAISSEAUX
    9. Dal Cortivo, L; Robert, I; Mangin, C; Sameshima, T; Kora, S; Gluckman, E; Benbunan, M; Marolleau, JP
      Cord blood banking: Volume reduction using "Procord" Terumo filter

      JOURNAL OF HEMATOTHERAPY & STEM CELL RESEARCH
    10. Park, S; Brice, P; Noguerra, ME; Simon, D; Rousselot, P; Kerneis, Y; Morel, P; Marolleau, JP; Gisselbrecht, C
      Myelodysplasias and leukemias after autologous stem cell transplantation for lymphoid malignancies

      BONE MARROW TRANSPLANTATION
    11. Lefrere, F; Makki, J; Marolleau, JP; Dal Cortivo, L; Alberti, C; Benbunan, M; Miclea, JM
      CD34+cells during leukapheresis procedures: relationship of volume processed and quantity of peripheral blood progenitor cells collected

      TRANSFUSION
    12. Borgen, E; Naume, B; Nesland, JM; Kvalheim, G; Beiske, K; Fodstad, O; Diel, I; Solomayer, EF; Theocharous, P; Coombes, RC; Smith, BM; Wunder, E; Marolleau, JP; Garcia, J; Pantel, K
      Standardization of the immunocytochemical detection of cancer cells in BM and blood: I. establishment of objective criteria for the evaluation of immunostained cells

      CYTOTHERAPY
    13. Pautier, P; Devidas, A; Delmer, A; Dombret, H; Sutton, L; Zini, JM; Nedelec, G; Molina, T; Marolleau, JP; Brice, P
      Angioimmunoblastic-like T-cell non Hodgkin's lymphoma: Outcome after chemotherapy in 33 patients and review of the literature

      LEUKEMIA & LYMPHOMA
    14. Farge, D; Breban, M; Guillevin, L; Piette, JC; Cabane, J; Cherin, P; Cosserat, J; Sicard, D; Ribaud, P; Marolleau, JP; Bouscary, D; Mariette, X; Gisselbrecht, C; Gluckman, E
      Bone marrow graft for the treatment of autoimmune diseases

      PRESSE MEDICALE
    15. Lefrere, F; Makke, J; Fermand, JP; Marolleau, JP; Dal Cortivo, L; Alberti, C; Mouton, V; Benbunan, M; Miclea, JM
      Blood stem cell collection using chemotherapy with or without systematic G-CSF: experience in 52 patients with multiple myeloma

      BONE MARROW TRANSPLANTATION
    16. Marolleau, JP; Dal Cortivo, L; Mills, B; Fermand, JP; Miclea, JM; Lotz, JP; Gisselbrecht, C; Benbunan, M
      Enrichment of peripheral blood CD34(+) cells for transplantation using a fully automated immunomagnetic cell selection system and a novel octapeptidereleasing agent

      BONE MARROW TRANSPLANTATION
    17. Rousselot, P; Labaume, S; Marolleau, JP; Larghero, J; Noguera, MH; Brouet, JC; Fermand, JP
      Arsenic trioxide and melarsoprol induce apoptosis in plasma cell lines andin plasma cells from myeloma patients

      CANCER RESEARCH
    18. Desgrandchamps, F; Teren, M; Dal Cortivo, L; Marolleau, JP; Bertheau, P; Villette, JM; Cortesse, A; Teillac, P; Le Duc, A; Hamdy, FC
      The effects of transurethral resection and cystoprostatectomy on dissemination of epithelial cells in the circulation of patients with bladder cancer

      BRITISH JOURNAL OF CANCER
    19. Breban, M; Dougados, M; Picard, F; Zompi, S; Marolleau, JP; Bocaccio, C; Heshmati, F; Mezieres, M; Dreyfus, F; Bouscary, D
      Intensified-dose (4 gm/m(2)) cyclophosphamide and granulocyte colony-stimulating factor administration for hematopoietic stem cell mobilization in refractory rheumatoid arthritis

      ARTHRITIS AND RHEUMATISM
    20. COHENHAGUENAUER O; RESTREPO LM; MASSET M; BAYER J; DALCORTIVO L; MAROLLEAU JP; BENBUNAN M; BOIRON M; MARTY M
      EFFICIENT TRANSDUCTION OF HEMATOPOIETIC CD34(-ORIGIN USING AN ORIGINAL RETROVIRAL VECTOR DERIVED FROM F-MULV-FB29 - IN-VITRO ASSESSMENT() PROGENITORS OF HUMAN)

      Human gene therapy
    21. SOCIE G; CAYUELA JM; RAYNAL B; ESPEROU H; FUND X; RAFFOUX C; DEVERGIE A; RIBAUD P; MAROLLEAU JP; PARQUET N; SIGAUX F; BRISON O; GLUCKMAN E
      INFLUENCE OF CD34 CELL SELECTION ON THE INCIDENCE OF MIXED CHIMERISM AND MINIMAL RESIDUAL DISEASE AFTER ALLOGENEIC UNRELATED DONOR TRANSPLANTATION

      Leukemia
    22. DALCORTIVO L; MAROLLEAU JP; GLUCKMAN E; CHAVINIE J; BROSSARD Y; BENBUNAN M
      THE PARIS CORD-BLOOD BANK

      Bone marrow transplantation
    23. MAROLLEAU JP; TERNAUX B; DALCORTIVO L; BROSSARD Y; GLUCKMAN E; BENBUNAN M
      T-CELL REPERTOIRE OF HUMAN UMBILICAL-CORD BLOOD

      Bone marrow transplantation
    24. ROUSSELOT P; LABAUME S; MAROLLEAU JP; LARGHERO J; BROUET JC; FERMAND JP
      ARSENIC TRIOXIDE AND MELARSOPROL INDUCE APOPTOSIS IN MYELOMA CELLS IN-VITRO AND INHIBIT PLASMA-CELLS GROWTH IN-VIVO

      British Journal of Haematology
    25. COSTELLO R; SAINTY D; FERMAND JP; DELMER A; DIVINE M; MAROLLEAU JP; GASTAUT JA; DOMBRET H; CHAIBI P
      PLASMA-CELL LEUKEMIA (PCL) - A MULTICENTRIC RETROSPECTIVE STUDY

      British Journal of Haematology
    26. CHABANNON C; CORNETTA K; LOTZ JP; ROSENFELD C; SHLOMCHIK M; YANOVITCH S; MAROLLEAU JP; SLEDGE G; NOVAKOVITCH G; SROUR EF; BURTNESS B; CAMERLO J; GRAVIS G; LEEFISCHER J; FAUCHER C; CHABBERT I; KRAUSE D; MARANINCHI D; MILLS B; KUNKEL L; OLDHAM F; BLAISE D; VIENS P
      HIGH-DOSE CHEMOTHERAPY FOLLOWED BY REINFUSION OF SELECTED CD34(-BLOODCELLS IN PATIENTS WITH POOR-PROGNOSIS BREAST-CANCER - A RANDOMIZED MULTICENTER STUDY() PERIPHERAL)

      British Journal of Cancer
    27. AGBALIKA F; MARIETTE X; MAROLLEAU JP; FERMAND JP; BROUET JC
      DETECTION OF HUMAN-HERPESVIRUS-8 DNA IN BONE-MARROW BIOPSIES FROM PATIENTS WITH MULTIPLE-MYELOMA AND WALDENSTROMS MACROGLOBULINEMIA

      Blood
    28. Cohen-Haguenauer, O; Masset, M; Carteau, AE; Setterblad, N; Kazal, I; Bedel, JF; Demerens, C; Dal Cortivo, L; Marolleau, JP; Benbunan, M; Boiron, M; Peault, B; Marty, M
      A novel retrovirus vector derived from Fr-MuLV FB29 mediating transductionof haematopoietic cells

      EUROCANCER 98
    29. MARIN GH; DALCORTIVO L; CAYUELA JM; MAROLLEAU JP; PAUTIER P; COJEANZELEK I; BRICE P; MAKKE J; BENBUNAN M; GISSELBRECHT C
      PERIPHERAL-BLOOD STEM-CELL CD34+ AUTOLOGOUS TRANSPLANT IN RELAPSED FOLLICULAR LYMPHOMA

      HEMATOLOGY AND CELL THERAPY
    30. TIRELLI U; ERRANTE D; SANTAROSSA S; SPINA M; GISSELBRECHT C; MAROLLEAU JP; KERNEIS Y; RIDOLFO A; BOTTURA P; PAN A; DELLEFOGLIE P; ROSSI G; TAVIO M; VACCHER E
      EPIRUBICIN, BLEOMYCIN, VINBLASTINE AND PREDNISONE (EBVP) CHEMOTHERAPY(CT) IN COMBINATION WITH ANTIRETROVIRAL THERAPY AND PRIMARY USE OF G-CSF FOR PATIENTS (PTS) WITH HODGKINS-DISEASE AND HIV-INFECTION (HD-HIV)

      Journal of acquired immune deficiency syndromes and human retrovirology
    31. GISSELBRECHT C; HAIOUN C; LEPAGE E; BASTION Y; TILLY H; BOSLY A; DUPRIEZ B; MARIT G; HERBRECHT R; DECONINCK E; MAROLLEAU JP; YVER A; DABOUZHARROUCHE F; COIFFIER B; REYES F
      PLACEBO-CONTROLLED PHASE-III STUDY OF LENOGRASTIM (GLYCOSYLATED RECOMBINANT HUMAN GRANULOCYTE-COLONY-STIMULATING FACTOR) IN AGGRESSIVE NON-HODGKINS-LYMPHOMA - FACTORS INFLUENCING CHEMOTHERAPY ADMINISTRATION

      Leukemia & lymphoma
    32. COHENHAGUENAUER O; RESTREPO LM; BAYER J; MASSET M; NEVO N; DALCORTIVO L; MAROLLEAU JP; MARTY M
      DESIGN AND EVALUATION OF A NOVEL FRIEND-VIRUS RETROVIRAL VECTOR FOR GENE-THERAPY

      European journal of cancer
    33. GUARDIOLA P; LACASSAGNE MN; BENBUNAN M; DALCORTIVO L; MAROLLEAU JP
      FLT3-L VERSUS SCF FOR THE GENERATION OF DENDRITIC CELLS FROM PERIPHERAL-BLOOD CD34(-CELLS() HEMATOPOIETIC STEM)

      Experimental hematology
    34. LACASSAGNE MN; GUARDIOLA P; TERNAUX B; BENBUNAN M; MAROLLEAU JP
      USE OF A SERUM-FREE MEDIUM FOR GENERATION OF DENDRITIC CELLS FROM CD34(-CELLS() HUMAN STEM)

      Blood
    35. ZINI JM; TERNAUX B; ROCHA V; ROCHA V; DALCORTIVO L; ALONSO R; GLUCKMAN E; BENBUNAN M; MAROLLEAU JP
      ISOLATION OF CD34-VIVO EXPANSION OF CORD-BLOOD CELLS - IMPACT OF COCULTURE WITH UMBILICAL VEIN ENDOTHELIAL-CELLS (HUVEC)( CELLS IS NOT ESSENTIAL FOR EX)

      Blood
    36. MICLEA JM; MAKKI J; GOULEY C; BOULENGER G; MOUTON V; DALCORTIVO L; MAROLLEAU JP; DEREYS S; BENBUNAN M; GOODRICH R
      ENHANCEMENT OF THE COBE SPECTRA(TM) AUTOPBSC(TM) SYSTEM TO COLLECT PBPC - REDUCED NEUTROPHIL AND PLATELET CONTAMINATION AND COLLECTION VOLUME

      Blood
    37. DALCORTIVO L; ROBERT I; EXTRA JM; LOTZ JP; BENBUNAN M; MAROLLEAU JP; ZINI JM
      IMMUNOCYTOCHEMICAL DETECTION OF TUMOR-CELLS IN PERIPHERAL-BLOOD STEM-CELL COLLECTION (PBSC) FROM PATIENTS WITH ADVANCED OVARIAN-CARCINOMA

      Blood
    38. MAROLLEAU JP; ESPEROU H; DALCORTIVO L; ROBERT I; PARQUET N; ZINI JM; TRAINEAU R; GLUCKMAN E; BENBUNAN M
      BONE-MARROW CD34-300 BAXTER) IN ALLOGENIC BONE-MARROW TRANSPLANTATIONWITH UNRELATED DONOR (UD. BMT) - PROCESSING RESULTS( SELECTION BY IMMUNOMAGNETIC METHOD (ISOLEX)

      Blood
    39. MALPHETTES M; MAROLLEAU JP; BRECHIGNAC S; RABIAN C; AUTRAN B; DEBRE P; BROUET JC; FERMAND JP
      IMMUNE RECONSTITUTION AFTER CD34(-MYELOMA() PURIFIED AUTOLOGOUS PBSC TRANSPLANTATION PATIENTS WITH MULTIPLE)

      Blood
    40. ESPEROU H; MAROLLEAU JP; ROCHA V; DALCORTIVO L; SEDKI M; PARQUET N; RAFFOUX C; TRAINEAU R; SOCIE G; BENBUNAN M; GLUCKMAN E
      ENRICHED CD34-MARROW CELLS WITH ISOLEX-300 (BAXTER(TM)) DEVICES REDUCE SEVERE GRAFT-VERSUS-HOST DISEASE (GVHD) IN ALLOGENEIC BONE-MARROW TRANSPLANTATION WITH UNRELATED DONOR (UD-BMT)( BONE)

      Blood
    41. BACCARD M; MAROLLEAU JP; RYBOJAD M
      MIDDLE-TERM EVOLUTION OF PATIENTS WITH ADVANCED CUTANEOUS T-CELL LYMPHOMA TREATED WITH HIGH-DOSE RECOMBINANT INTERLEUKIN-2

      Archives of dermatology
    42. COHENHAGUENAUER O; RESTREPO LM; MASSET M; BAYER J; PELLERAIN N; DALCORTIVO L; MAROLLEAU JP; BENBUNAN M; BOIRON M; MARTY M
      TRANSDUCTION OF HUMAN CD34-MULV AND CLINICALLY RELEVANT PROCEDURES( HEMATOPOIETIC PROGENITORS OF VARIOUS ORIGIN USING AN ORIGINAL RETROVIRUS VECTOR DERIVED FROM FR)

      HEMATOLOGY AND CELL THERAPY
    43. BRICE P; MAROLLEAU JP; PAUTIER P; MAKKE J; CAZALS D; DOMBRET H; DAGAY MF; BENBUNAN M; GISSELBRECHT C
      HEMATOLOGIC RECOVERY AND SURVIVAL OF LYMPHOMA PATIENTS AFTER AUTOLOGOUS STEM-CELL TRANSPLANTATION - COMPARISON OF BONE-MARROW AND PERIPHERAL-BLOOD PROGENITOR CELLS

      Leukemia & lymphoma
    44. ZINI JM; MAROLLEAU JP; MIELEA JM; MOUTON V; BENBUNAN M
      EXPRESSION OF ADHESION MOLECULES ON CD34-STUDIES BETWEEN PERIPHERAL-BLOOD AND BONE-MARROW STEM-CELLS( CELLS COMPARATIVE)

      Experimental hematology
    45. ZEITOUN C; BACCARD M; MAROLLEAU JP; RYBOJAD M; BARUCHEL A; MOREL P; BRICE P
      AUTOLOGOUS BONE-MARROW TRANSPLANTATION IN THE TREATMENT OF CUTANEOUS LYMPHOMA

      Annales de dermatologie et de venereologie
    46. DALCORTIVO L; ROBERT I; BERTHEAU P; EXTRA JM; LOTZ JP; ZINAI A; ZINI JM; MICLEA JM; BENBUNAN M; MAROLLEAU JP
      IMMUNOCYTOCHEMICAL DETECTION OF RESIDUAL TUMOR-CELLS IN BLOOD AND STEM-CELLS COLLECTIONS OF PATIENTS TREATED FOR BREAST AN OVARIAN-CANCER

      Blood
    47. FERMAND JP; MAROLLEAU JP; BRECHIGNAC S; MAKKE J; MCINTYRE E; BENBUNAN M; BROUET JC
      SEQUENTIAL HIGH-DOSE THERAPY (HDT) WITH CD34-BLOOD STEM-CELL (PBSC) TRANSPLANTATION IN MULTIPLE-MYELOMA (MM)( SELECTED AUTOLOGOUS PERIPHERAL)

      Blood
    48. LEFRERE F; MAKKE J; DALCORTIVO L; MAROLLEAU JP; BENBUNAN M; VARET B; MICLEA JM
      IMPORTANCE OF THE INTRODUCTION DATE OF G-CSF AFTER CHEMOTHERAPY ON PBSC COLLECTION

      Blood
    49. MAROLLEAU JP; LACASSAGNE MN; ROHRLICH P; ZINI JM; DALCORTIVO L; MICLEA JM; TERNAUX B; BENBUNAN M
      EX-VIVO GENERATION OF DENDRITIC CELLS (DC) FROM PERIPHERAL-BLOOD STEMOR MARROW CD34+ CELLS OBTAINED FROM ONCOLOGY PATIENTS OR NORMAL DONORS

      Blood
    50. MAROLLEAU JP; BRICE P; DALCORTIVO L; FERMAND JP; ROBERT I; MICLEA JM; CHAIBI P; GISSELBRECHT C; MILLS B; KUNKEL L; OLDHAM F; BENBUNAN M
      CD34-300) FOR PATIENTS WITH MALIGNANCIES( SELECTION BY IMMUNOMAGNETICSELECTION (ISOLEX(R))

      Blood
    51. HERMINE O; HAIOUN C; LEPAGE E; DAGAY MF; BRIERE J; LAVIGNAC C; FILLET G; SALLES G; MAROLLEAU JP; DIEBOLD J; REYES F; GAULARD P
      PROGNOSTIC-SIGNIFICANCE OF BCL-2 PROTEIN EXPRESSION IN AGGRESSIVE NON-HODGKINS-LYMPHOMA

      Blood
    52. BRICE P; GODIN S; LIBERT O; MAROLLEAU JP; MAKKI J; EXTRA JM; FAURE P; GISSELBRECHT C
      EFFECT OF LENOGRASTIN ON THE COST OF AUTOLOGOUS BONE-MARROW TRANSPLANTATION - A PRELIMINARY COMMUNICATION

      PharmacoEconomics
    53. HUNAULT M; DOMBRET H; GARDIN C; RIO B; HERMINE O; BRICE P; DEVIDAS A; TURLURE P; ZINI JM; NEDELLEC G; SUTTON L; MICLEA JM; DEREVEL T; DUPUY E; PAUTIER P; MAROLLEAU JP; DELMER A
      HEMATOPOIETIC GROWTH-FACTORS IN DRUG-INDUCED AGRANULOCYTOSIS

      Leukemia
    54. LEFRERE F; MAKKE J; MAROLLEAU JP; BENBUNAN M; MICLEA JM
      IMPACT OF PREVIOUS THERAPY ON PERIPHERAL-BLOOD STEM-CELL (PBSC) COLLECTION

      Transfusion
    55. DOMBRET H; MAROLLEAU JP
      DE-NOVO ACUTE MYELOID-LEUKEMIA IN PATIENTS WITH CROHNS-DISEASE

      Nouvelle revue francaise d'hematologie
    56. BERTHOU C; MAROLLEAU JP; LAFAURIE C; SOULIE A; DALCORTIVO L; BOURGE JF; BENBUNAN M; SASPORTES M
      GRANZYME-B AND PERFORIN LYTIC PROTEINS ARE EXPRESSED IN CD34(-BLOOD PROGENITOR CELLS MOBILIZED BY CHEMOTHERAPY AND GRANULOCYTE-COLONY-STIMULATING FACTOR() PERIPHERAL)

      Blood
    57. BASTION Y; BRICE P; HAIOUN C; SONET A; SALLES G; MAROLLEAU JP; ESPINOUSE D; REYES F; GISSELBRECHT C; COIFFIER B
      INTENSIVE THERAPY WITH PERIPHERAL-BLOOD PROGENITOR-CELL TRANSPLANTATION IN 60 PATIENTS WITH POOR-PROGNOSIS FOLLICULAR LYMPHOMA

      Blood
    58. MICLEA JM; MAKKI J; LEFRERE F; ROUSSELOT P; PAUTIER P; OCKSENHENDLER E; LOTZ JP; TERNAUX B; MAROLLEAU JP; DALCORTIVO L; BENBUNAN M
      SUCCESSFUL PBPC HARVESTING WITH G-CSF ALONE, AFTER PREVIOUS MOBILIZATION FAILURE BY BOTH CHEMOTHERAPY AND GROWTH-FACTOR

      Blood
    59. CHABANNON C; VIENS P; CAMERLO J; GRAVIS G; FAUCHER C; NOVAKOVITCH G; CORNETTA K; LOTZ JP; MAROLLEAU JP; ROSENFELD C; CHABBERT I; MANNONI P; MARANINCHI D; MILLS B; OLDHAM F; BLAISE D
      HIGH-DOSE CHEMOTHERAPY FOLLOWED BY REINFUSION OF SELECTED CD34-BLOOD CELLS IN PATIENTS WITH POOR-RISK BREAST-CANCER - A RANDOMIZED MULTICENTER STUDY( PERIPHERAL)

      Blood
    60. MAROLLEAU JP; BACCARD M; FLAGEUL B; RYBOJAD M; LAROCHE L; VEROLA O; BRANDELY M; MOREL P; GISSELBRECHT C
      HIGH-DOSE RECOMBINANT INTERLEUKIN-2 IN ADVANCED CUTANEOUS T-CELL LYMPHOMA

      Archives of dermatology
    61. GEISSMANN F; DEROUIN F; MAROLLEAU JP; GISSELBRECHT C; BRICE P
      DISSEMINATED TOXOPLASMOSIS FOLLOWING AUTOLOGOUS BONE-MARROW TRANSPLANTATION

      Clinical infectious diseases
    62. BRICE P; GODIN S; LIBERT O; MAROLLEAU JP; MAKKI J; EXTRA JM; FAURE P; GISSELBRECHT C
      EFFECT OF GRANULOCYTE GROWTH-FACTOR ON TH E COST OF BONE-MARROW AUTOGRAFTS IN ONCOHAEMATOLOGY

      La Presse medicale
    63. BRICE P; DIVINE M; MAROLLEAU JP; HAIOUN C; DALCORTIVO L; SITTHY X; BEAUJEAN F; NOROL F; BENBUNAN M; REYES F; GISSELBRECHT C
      COMPARISON OF AUTOGRAFTING USING MOBILIZED PERIPHERAL-BLOOD STEM-CELLS WITH AND WITHOUT GRANULOCYTE-COLONY-STIMULATING FACTOR IN MALIGNANT-LYMPHOMAS

      Bone marrow transplantation
    64. BRICE P; PAUTIER P; MAROLLEAU JP; CASTAIGNE S; GISSELBRECHT C
      PREGNANCY AFTER AUTOLOGOUS BONE-MARROW TRANSPLANTATION FOR MALIGNANT-LYMPHOMAS

      Nouvelle revue francaise d'hematologie
    65. MAROLLEAU JP; MULLEN M; LAW P; DALCORTIVO L; MURUYAMA M; MILLS B; HO A; GISSELBRECHT C
      CD34-300 DEVICE - APPLICATION TO MULTIPLE CYCLES OF HIGH-DOSE CHEMOTHERAPY IN LYMPHOMAS( SELECTION WITH ISOLEX)

      Blood
    66. GISSELBRECHT C; BASTION Y; HAIOUN C; LEPAGE E; TILLY H; BOSLY A; DUPRIEZ B; MARIT G; DECONINCK E; MAROLLEAU JP; YVER A; COIFFIER B; REYES F
      PLACEBO-CONTROLLED PHASE-III TRIAL OF LENOGRASTIM (GLYCOSYLATED RECOMBINANT HUMAN G-CSF) IN AGGRESSIVE NON-HODGKINS-LYMPHOMA (NHL)

      Blood
    67. HUNAULT M; BRICE P; TURLURE P; ZINI JM; DEVIDAS A; NEDELEC G; SUTTON L; MAROLLEAU JP; GARDIN C; DEREVEL T; DUPUY E; PAUTIER P; MICLEA JM; DOMBRET H; DELMER A
      MANTLE CELL LYMPHOMA (MCL) - CLINICAL-FEATURES AND TREATMENT RESULTS IN 42 PATIENTS

      Blood
    68. BRICE P; MAROLLEAU JP; PEYTCHEV D; GIACHETTI S; SITTHY X; DJENANDER F; BENBUNAN M; GISSELBRECHT C
      GRANULOCYTE-COLONY-STIMULATING FACTOR (G-CSF) TO HARVEST MOBILIZED CIRCULATING HEMATOPOIETIC STEM-CELLS FOR AUTOTRANSPLANTATION

      Leukemia
    69. ARACTINGI S; MAROLLEAU JP; DAGAY MF; FLAGEUL B; GISSELBRECHT C; DUBERTRET L
      CUTANEOUS EPIDERMOTROPIC T-GAMMA-DELTA LY MPHOMA

      Annales de dermatologie et de venereologie
    70. ARACTINGI S; MAROLLEAU JP; CORDOLIANI F; DANIEL MT; DUBERTRET L
      SUB-CUTANEOUS LOCALIZATIONS OF BURKITT-LY MPHOMA AFTER CELIOSCOPY

      Annales de dermatologie et de venereologie
    71. BRICE P; RAIN JD; FRIJA J; MIAUX Y; MAROLLEAU JP; TREDANIEL J; FERME C; HENNEQUIN C; GISSELBRECHT C
      RESIDUAL MEDIASTINAL MASS IN MALIGNANT-LYMPHOMA - VALUE OF MAGNETIC-RESONANCE-IMAGING AND GALLIUM SCAN

      Nouvelle revue francaise d'hematologie
    72. FAUTREL B; MAROLLEAU JP; CHARLEUX F; BRICE P; FRIJA J; GISSELBRECHT C
      PANCREATIC AND HEPATIC PLASMACYTOMAS - AN EXCEPTIONAL CASE

      Nouvelle revue francaise d'hematologie
    73. BAZARBACHI A; SCROBOHACI ML; GISSELBRECHT C; MAROLLEAU JP; MANSI A; BRICE P; GORRA P; DROUET L
      CHANGES IN PROTEIN-C, FACTOR-VII AND ENDOTHELIAL MARKERS AFTER AUTOLOGOUS BONE-MARROW TRANSPLANTATION - POSSIBLE IMPLICATIONS IN THE PATHOGENESIS OF VENOOCCLUSIVE DISEASE

      Nouvelle revue francaise d'hematologie
    74. SCROBOHACI ML; DANIEL MT; LEVY Y; MAROLLEAU JP; BROUET JC
      EXPRESSION OF GPIB ON PLASMA-CELLS IN A PATIENT WITH MONOCLONAL IGG AND ACQUIRED VON-WILLEBRAND DISEASE

      British Journal of Haematology


ASDD Area Sistemi Dipartimentali e Documentali, Università di Bologna, Catalogo delle riviste ed altri periodici
Documento generato il 22/10/20 alle ore 00:39:27